Scientists have come up with an innovative solution to improve the effectiveness of cannabidiol to treat epilepsy, multiple sclerosis and other neurodegenerative diseases.

Single-molecule biophysics is the study of the dynamics and interactions of individual biomolecules to understand how they carry out their functions in living cells. For example, monitoring the ...

Health Canada is exploring a regulatory pathway for the authorization of health products containing cannabidiol (CBD) that could be accessed without a prescription. Our goal is to protect the health ...

As indicated in the 2024-2026 Forward Regulatory Plan, Health Canada is exploring a regulatory pathway for the authorization of health products containing cannabidiol, commonly referred to as CBD, ...

Ativan (lorazepam): Capsaicin reduces the metabolism of lorazepam, a drug taken for seizures and mood disorders. Cannabidiol (CBD) is a compound found in the marijuana plant. Unlike other compounds in ...

Detailed price information for Cardiol Therapeutics (CRDL-Q) from The Globe and Mail including charting and trades.

The result is a three-dimensional Fourier, or electron-density, map of the unit cell, which for the first time reveals the general nature of the tertiary structure of a protein molecule.

Takeda has returned to BridGene Biosciences for another small-molecule collaboration—this time focused on immunology as well as neurology. BridGene’s pursuit of undruggable targets is enabled ...

However, the current use of supplements containing cannabidiol (CBD) in equines is based on anecdotal evidence, without the support of sufficient pharmacokinetic studies. In humans, the concentration ...

Department of Neurology and Stroke Center, The first Affiliated Hospital & Clinical Neuroscience Institute, Key Lab of Basic and Translational Research of Pan-vascular Diseases, Jinan University, ...

Cannabidiol (CBD), the component in cannabis often used for therapeutic treatments, is increasingly being used during pregnancy as a means of managing symptoms such as nausea, anxiety and sleep.

The Company’s lead small molecule drug candidate, CardiolRx™ (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease.